LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma - Université de Rennes Access content directly
Journal Articles HPB Year : 2016

LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma

Abstract

no abstract

Dates and versions

hal-01310762 , version 1 (03-05-2016)

Identifiers

Cite

D. Bergeat, A. Fautrel, Bruno Turlin, A. Merdrignac, M. Rayar, et al.. LOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. HPB, 2016, Abstracts of the 11th International Congress of the European-African Hepato-Pancreato-Biliary Association, 21-24 April 2015, Manchester, UK, 18, Supplement 2, pp.e863. ⟨10.1016/j.hpb.2016.01.490⟩. ⟨hal-01310762⟩
36 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More